Glycan-based diagnostics to measure biological age and chronic inflammation.
| Date | Round | Amount |
|---|---|---|
| Dec 2025 | Funding round GlycanAge raised $8.7 million led by Fifth Quarter Ventures to take its glycan tests from longevity into hospital diagnostics. | $8.7M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.